Gene · 1240
Papers1,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,391
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic Messengers: Extracellular Vesicles as Central Mediators of Metabolic Reprogramming in Renal Cell Cancer. | Biomedicines | 2026 | 41751181 | PubTator, text mining | PubMed |
| Coronary artery spasm: mechanisms, risk factors, and translational strategies for precision management. | Front Cardiovasc Med | 2026 | 41736832 | PubTator, text mining | PubMed |
| ChemR23 signalling as a potential therapeutic target in atherosclerosis and cardiovascular diseases. | Cardiovasc Res | 2026 | 41609295 | PubTator, text mining | PubMed |
| Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial. | Nat Commun | 2026 | 41593097 | PubTator, text mining | PubMed |
| The potential of deep learning on the discovery of new genes implicated in differences of sex development. | Comput Struct Biotechnol J | 2026 | 41550136 | PubTator, text mining | PubMed |
| Targeting the CMKLR1-Mediated Signaling Rebalances Immunometabolism State in Middle-Age Testicular Macrophages. | Adv Sci (Weinh) | 2026 | 41538650 | PubTator, text mining | PubMed |
| The liver as a metabolic and immune hub in Alzheimer's disease: From mechanisms to therapeutic opportunities. | J Prev Alzheimers Dis | 2026 | 41529520 | PubTator, text mining | PubMed |
| Molecular Signaling and Biased Agonism of the CHEMR23 Receptor: Implications for Inflammation Resolution and Bone Remodeling. | Curr Protein Pept Sci | 2026 | 41486998 | PubTator, text mining | PubMed |
| Receptor-Mediated Shuttling of a D-Amino Acid Peptide Achieves High Nanomolar Cytosolic Concentrations. | J Am Chem Soc | 2026 | 41422545 | PubTator, text mining | PubMed |
| Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction. | Nat Genet | 2026 | 41419686 | PubTator, text mining | PubMed |
| So3D: a comprehensive three-dimensional spatial omics resource for decoding tissue architecture in physiology and disease. | Nucleic Acids Res | 2026 | 41062448 | PubTator, text mining | PubMed |
| Chemerin, OPG, and WPOI as Markers of Bone Invasion and Prognosis in Oral Squamous Cell Carcinoma. | J Oral Pathol Med | 2026 | 41055393 | PubTator, text mining | PubMed |
| PAD4 promotes macrophage migration to aggravate tubulointerstitial injury in diabetic kidney disease. | Mol Ther | 2026 | 41054305 | PubTator, text mining | PubMed |
| Chemerin as a Mediator of Hypertension and Cardiometabolic Diseases (A Comprehensive Review). | Curr Hypertens Rep | 2025 | 41457200 | PubTator, text mining | PubMed |
| Multiscale Computational Dissection of CCRL2-Mediated Chemerin Presentation. | J Chem Inf Model | 2025 | 41380116 | PubTator, text mining | PubMed |
| Chemerin and the Gut: From Inflammation to Cancer. | Biomedicines | 2025 | 41301712 | PubTator, text mining | PubMed |
| CMKLR1/PKA signaling reinforces sonic hedgehog pathway to promote medulloblastoma pathogenesis. | Oncogenesis | 2025 | 41249112 | PubTator, text mining | PubMed |
| Chemerin in Pulmonary Fibrosis: Advances in Mechanistic and Fundamental Research. | Biomolecules | 2025 | 41154697 | PubTator, text mining | PubMed |
| Retraction Note: Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy. | Cell Death Dis | 2025 | 41152256 | PubTator, text mining | PubMed |
| Exploration of effective biomarkers and infiltrating immune cells in metastatic colorectal cancer based on bioinformatics analysis. | Sci Rep | 2025 | 41006647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1240/papers?page=2